A collaboration of multidisciplinary experts on the delivery of pharmaceutical
aerosols was facilitated by the European Respiratory Society (ERS) and the International Society
for Aerosols in Medicine (ISAM), in order to draw up a consensus statement with clear, up-to-date
recommendations that enable the pulmonary physician to choose the type of aerosol delivery
device that is most suitable for their patient. The focus of the consensus statement is the patientuse
aspect of the aerosol delivery devices that are currently available.